amorphexusa.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.amorphexusa.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change
Meta Tags
Title Amorphex Therapeutics |
Description Amorphex is developing TODDD™, a patented device that corrects the many problems underermining current topical ocular
Keywords N/A
Server Information
WebSite amorphexusa faviconamorphexusa.com
Host IP 185.230.63.107
Location -
Related Websites
Site Rank
More to Explore
amorphexusa.com Valuation
US$2,060,936
Last updated: 2023-05-18 11:40:53

amorphexusa.com has Semrush global rank of 5,135,678. amorphexusa.com has an estimated worth of US$ 2,060,936, based on its estimated Ads revenue. amorphexusa.com receives approximately 237,801 unique visitors each day. Its web server is located in -, with IP address 185.230.63.107. According to SiteAdvisor, amorphexusa.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$2,060,936
Daily Ads Revenue US$1,903
Monthly Ads Revenue US$57,073
Yearly Ads Revenue US$684,865
Daily Unique Visitors 15,854
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
amorphexusa.com. A 3600 IP: 185.230.63.107
amorphexusa.com. A 3600 IP: 185.230.63.186
amorphexusa.com. A 3600 IP: 185.230.63.171
amorphexusa.com. NS 86400 NS Record: ns0.wixdns.net.
amorphexusa.com. NS 86400 NS Record: ns1.wixdns.net.
amorphexusa.com. MX 3600 MX Record: 0 amorphexusa-com.mail.protection.outlook.com.
HtmlToTextCheckTime:2023-05-18 11:40:53
top of page Home Company Team Current State of Development Demo Videos Publications Pipeline Contact Platform Technology for Ocular Drug Delivery Delivering drug into the eye is critical for the treatment of many ophthalmic diseases including glaucoma, one of the leading causes of irreversible blindness in the world. Amorphex has developed TODDD™, a soft, patented device that can deliver drug to the eye continuously, around the clock for multiple months without interruption. Replacing difficult and frequently inadequate eye drop therapy, TODDD™ is comfortably worn by the patient under their eyelid and is easily replaced at prescribed intervals of months or weeks, depending on the treated condition. This safe, non-invasive, platform technology solves the many challenges of repetitious daily eye drop dosing such as difficulties with drop instillation, partial dosing, daily forgetfulness, and continuing adherence to therapy. ​ TODDD™ provides accurate delivery into the eye, getting the
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Wed, 15 Jun 2022 08:36:54 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.amorphexusa.com/
strict-transport-security: max-age=3600
Age: 22997
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=42
X-Seen-By: gv/XVF9HsGpk8A2KWukUzOwfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVgjB5iMgVduhJkO1xgMq9zO,m0j2EEknGIVUW/liY8BLLp4sYwYx2UgZC4DZhzpOwcVGkFvVdT2Nq6f3Hedj7ewB,2d58ifebGbosy5xc+FRalqD37N8XlbeUqtlcmA4zbZuGIOl+CBofm3Zws5QMejPS8Q5jt3i/UdmpddWmoWmoBA==,2UNV7KOq4oGjA5+PKsX47IZT0kJPktlWZbg/bPfWvrkfbJaKSXYQ/lskq2jK6SGP
Cache-Control: no-cache
X-Wix-Request-Id: 1655282214.29020627123341325310
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Wed, 15 Jun 2022 08:36:54 GMT
content-type: text/html; charset=UTF-8
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
x-wix-request-id: 1655282214.756206400462454290
content-language: en
strict-transport-security: max-age=3600
age: 0
set-cookie: ssr-caching=cache#desc=miss#varnish=miss#dc#desc=42; Max-Age=20; Expires=Wed, 15 Jun 2022 08:37:14 GMT
server-timing: cache;desc=miss, varnish;desc=miss, dc;desc=42
x-seen-by: wmgbEcS9zOENaefw7bU4YaZln+qva608hH1gdDiqWLc=,VtqAe8Wu9wvSsl49B/X4+ewfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVihnQVYpfofwhBhTRHXuy5t,m0j2EEknGIVUW/liY8BLLupO/enPqTWY4Qy4iOZWWztGkFvVdT2Nq6f3Hedj7ewB,2d58ifebGbosy5xc+FRalnDDB1/wPIiGXsrj5G04O2iBEqI0WA586lsRg0gc+OqEgEbFRH9wrtvdKymRgTobag==,2UNV7KOq4oGjA5+PKsX47FoWDRZqj6HxHxlOmsTeGVJYgeUJqUXtid+86vZww+nL,osV03DUdKaEVOGwoQFgPYnbMEEL4GXHTZQ4DZvOQ6p0=,QCwmNx1TNUYLIqEqVA58OMnl7paBT3jRd6eujdXoUgZjZDp9586VeCA/6HBLmgxZWIHlCalF7YnfvOr2cMPpyw==,sQ19iEk473qMiaixh4sAThIxCjmNBXrsNRMEwtv26Dk=,LoUK8/saGAmOxZWtpubo2lVDXC6j89fwqpHSGjaEHZU+TJgMNrpjoonpx97BI4m6EwTv8TnNNau7Rf1uShqY9A==,sQ19iEk473qMiaixh4sATniR1pjqljlDF082EGHwlG4=,sQ19iEk473qMiaixh4sATibM8kqXlLgSPwADgi1Dr40=,/a5ccLSK1HEmwPNg/x6OurnmRMBfMpfr3Dalou4LnZf1mxlevEuHckhKB8TBZS9R0l0ebLuxMHuEkkjX2yJbyA==
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
x-content-type-options: nosniff
set-cookie: TS01e85bed=018d9e98b6a8caa6acde53db50e81964541094b03e173462b2999d6f178f8c864d87eac10207841ed13ab843c44e31c849a5ecb120; Path=/; SameSite=none; Secure
server: Pepyaka/1.19.10
amorphexusa.com Whois Information
Domain Name: AMORPHEXUSA.COM
Registry Domain ID: 1427908370_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2022-03-21T12:47:41Z
Creation Date: 2008-03-20T16:54:50Z
Registry Expiry Date: 2023-03-20T16:54:50Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS0.WIXDNS.NET
Name Server: NS1.WIXDNS.NET
DNSSEC: unsigned
>>> Last update of whois database: 2022-06-15T09:38:58Z <<<